亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

  • 常州恒達(dá)生物科技有限公司
  • 主營(yíng):生物技術(shù)開(kāi)發(fā)與技術(shù)服務(wù),化工產(chǎn)品的技術(shù)開(kāi)發(fā)與技術(shù)服務(wù),環(huán)保技術(shù)開(kāi)發(fā)與技術(shù)服務(wù),化工原料及產(chǎn)品(除危險(xiǎn)品)的銷售。
  • 制造商  
江蘇/常州市
江蘇/鹽城市
湖北/武漢市
湖北/武漢市
湖北/武漢市
山東/濟(jì)南市
上海
浙江/湖州市
天津
江蘇/泰州市
  • 北京海步醫(yī)藥科技股份有限公司
  • 主營(yíng):技術(shù)開(kāi)發(fā)、技術(shù)轉(zhuǎn)讓、技術(shù)咨詢、技術(shù)服務(wù);銷售化工產(chǎn)品、化學(xué)試劑;貨物進(jìn)出口、技術(shù)進(jìn)出口、代理進(jìn)出口。
  • 制造商  
北京
陜西/西安市
  • 浙江東陽(yáng)天宇化工有限公司
  • 主營(yíng):主要從事4-二甲氨基吡啶,五氮化三磷,異硫氰酸苯酯,1-苯基-5-巰基四氮唑,5-氨基四氮唑,5-苯基四氮唑,N-羥基鄰苯二甲酰亞胺(NOP),無(wú)水甜菜堿及甜菜堿鹽酸鹽等精細(xì)化工原料及醫(yī)藥、農(nóng)藥中間體的開(kāi)發(fā)、生產(chǎn)和銷售。產(chǎn)品廣泛應(yīng)用于醫(yī)藥、農(nóng)藥合成,汽車安全裝置、感光材料、照明、電鍍、印染、化妝品、助劑等多項(xiàng)領(lǐng)域。
  • 制造商,貿(mào)易商  
浙江/金華市
天津
山東/濟(jì)南市
上海
湖北/武漢市
湖北/武漢市
山東/濟(jì)南市
湖北/黃石市
切換頻道
相關(guān)搜索
今日排行
本周排行
本月排行
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |